CCL2 and cancer: Due to the contribution of the CCL2/CCR2 and CXCL1/CXCR2 axes to the pathology of various cancers, there have been attempts to develop CCR2 and CXCR2 antagonists, anticipating therapeutic benefits from CCR2 and CXCR2 inhibition.